1 active not recruiting. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Active not recruiting 1 |
Follow TP-05 (lotilaner) Low Dose: new trials by email Literature Review of TP-05 (lotilaner) Low Dose trials Research Report on TP-05 (lotilaner) Low Dose
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study to Evaluate Safety and Efficacy of TP-05 in Healthy Participants With Tick Exposure TP-05 (lotilaner) Low Dose, TP-05 (lotilaner) High Dose, Placebo - Lyme Disease | Phase 2 | Active not recruiting | Tarsus Pharmaceuticals, Inc. | 722 | 2026-03-09 | 2026-07-09 |
Bacterial Infections (1) · Bacterial Infections and Mycoses (1) · Borrelia Infections (1) · Gram-Negative Bacterial Infections (1) · Infections (1) · Lyme Disease (1) · Spirochaetales Infections (1) · Tick-Borne Diseases (1) · Vector Borne Diseases (1)
Tarsus Pharmaceuticals, Inc. (1)
United States (1)